09:09 AM EST, 03/08/2024 (MT Newswires) -- Structure Therapeutics ( GPCR ) reported a Q4 net loss Friday of $24.5 million, wider than the loss of $11.9 million a year earlier.

Analysts polled by Capital IQ expected a loss of $27.4 million.

As expected, no revenue for the quarter ended Dec. 31 was reported.

As of the quarter end, the company said it had $467.3 million in cash and cash equivalents, and expected it could fund operations through at least 2026.

Shares of the company were up over 2% in recent Friday premarket activity.

Price: 36.93, Change: +0.92, Percent Change: +2.55